Celsius: Riding Alani Nu Growth Story

Celsius Holdings reported Q1 revenue of $782.6M, up 137.7% YoY, driven almost entirely by Alani Nu’s explosive growth while the core Celsius brand still grew 6%. Gross margin eased to 48.3%, but earnings beat estimates and normalized gross margins remained above 50%, supporting robust EPS and EBITDA growth. Despite the strong quarter and positive growth outlook, the stock still trades near yearly lows.

Analysis

The market is still pricing CELH like a single-brand turnaround, but the quarter argues the business is becoming a platform with a second growth engine. That matters because Alani Nu’s contribution is not just additive revenue; it also diversifies retailer dependence, improves shelf leverage, and gives the company more pricing/promo flexibility into the next few resets. The core brand’s mid-single-digit growth suggests the legacy franchise is stabilizing rather than structurally degrading, which is the key debate for terminal multiple expansion.

The margin compression is the right place to stay skeptical, but it looks more like mix dilution and integration noise than a demand problem. If normalized gross margins can hold above 50%, incremental EBITDA should re-accelerate faster than most investors expect, because the operating leverage on a much larger revenue base is now meaningful. The second-order effect is that competitors relying on a weaker CELH execution narrative may be forced to defend share with heavier promo, which could pressure category economics before it hits CELH’s own top line.

The main risk is that the market underestimates how quickly the Alani contribution can normalize from “hypergrowth” to “high growth,” which would compress the near-term surprise factor. Over the next 1-3 months, the stock likely trades on whether management can prove margin recovery and avoid signs of retailer saturation; over 6-12 months, the real catalyst is whether CELH can sustain >20% consolidated growth without a gross margin reset. The contrarian view is that the stock may be too cheap if investors are anchoring on one quarter’s margin dip and missing that the company now has a broader demand base and better distribution economics than before.

Key Decisions for Investors

• Initiate a tactical long CELH position over the next 1-2 weeks on post-earnings weakness; target a 15-25% rebound if management guides to sustained normalized gross margins above 50% and continued double-digit growth.
• Use call spreads in CELH rather than stock for a 2-3 month view: buy near-dated upside while capping downside if the market focuses on temporary gross margin compression.
• Pair trade: long CELH / short a weaker packaged-beverage or energy-drink peer with slower growth and higher promo dependence over the next quarter; the thesis is relative gross profit momentum and better retailer leverage at CELH.
• If CELH rallies hard into the next print, trim 30-40% into strength and wait for confirmation of margin recovery, because the first reversal risk is an inventory or mix reset after the Alani surge normalizes.